- Report
- October 2023
Asia Pacific
From €1330EUR$1,500USD£1,152GBP
- Report
- October 2023
Africa, Middle East
From €1330EUR$1,500USD£1,152GBP
- Report
- October 2023
Europe
From €1330EUR$1,500USD£1,152GBP
- Report
- October 2023
North America
From €1330EUR$1,500USD£1,152GBP
- Report
- February 2026
- 150 Pages
China
From €4302EUR$4,850USD£3,725GBP
- Report
- February 2026
- 150 Pages
Germany
From €4302EUR$4,850USD£3,725GBP
- Report
- February 2026
- 150 Pages
Canada
From €4302EUR$4,850USD£3,725GBP
- Report
- February 2026
- 150 Pages
India
From €4302EUR$4,850USD£3,725GBP
- Report
- March 2025
- 150 Pages
Global
From €4302EUR$4,850USD£3,725GBP
- Report
- January 2024
- 150 Pages
Global
From €4302EUR$4,850USD£3,725GBP
- Report
- December 2025
- 21 Pages
Canada
From €4431EUR$4,995USD£3,837GBP
- Report
- December 2025
- 22 Pages
Australia
From €4431EUR$4,995USD£3,837GBP
- Report
- December 2025
- 21 Pages
India
From €4431EUR$4,995USD£3,837GBP
- Report
- December 2025
- 21 Pages
South Korea
From €4431EUR$4,995USD£3,837GBP
- Report
- December 2025
- 19 Pages
Italy
From €4431EUR$4,995USD£3,837GBP
- Report
- December 2025
- 21 Pages
Germany
From €4431EUR$4,995USD£3,837GBP
- Report
- December 2025
- 24 Pages
United Kingdom
From €4431EUR$4,995USD£3,837GBP
- Report
- October 2025
- 92 Pages
Oman
From €4302EUR$4,850USD£3,725GBP
- Report
- September 2025
- 71 Pages
Canada
From €1770EUR$1,995USD£1,532GBP
- Report
- January 2025
- 78 Pages
From €2617EUR$2,950USD£2,266GBP

Oxygen therapy is a form of respiratory therapy that involves the administration of oxygen to a patient in order to improve their breathing. It is used to treat a variety of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. Oxygen therapy is typically administered through a variety of devices, such as oxygen concentrators, oxygen tanks, and nasal cannulas. Oxygen concentrators are the most common type of device used, as they are able to provide a continuous supply of oxygen to the patient. Oxygen tanks are used when a patient needs a higher concentration of oxygen, while nasal cannulas are used for patients who need a lower concentration of oxygen.
The oxygen therapy market is a subset of the larger respiratory devices market, which includes a variety of products used to treat respiratory conditions. This market is expected to grow in the coming years, driven by an increasing prevalence of respiratory diseases, technological advancements, and an aging population.
Some of the major companies in the oxygen therapy market include Philips, ResMed, Invacare, and AirSep. Show Less Read more